N/A N=60 Randomized Double-blind Treatment

Comparison of Miller's Blade and Airtraq Laryngoscope in Children

Intubation, Intratracheal

Bottom Line

View on ClinicalTrials.gov: NCT02423317 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2016

Primary outcome: Primary: Time to Intubation — 15.13; 11.53 seconds

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Intubation with Miller's blade (Device); Intubation with Airtraq (Device)
Age: Pediatric · 2+ yrs
Sex: All
Sponsor: Government Medical College, Haldwani
Primary completion: May 2014

Outcome Measures

Outcome	Result	p-value
PRIMARY Time to Intubation	15.13; 11.53	—
SECONDARY Number of Intubation in First Attempts;	25; 29	—
SECONDARY Ease of Intubation.	5; 3	—
SECONDARY Percentage of Glottic Opening Scoring.	75; 100	—
SECONDARY Overall Intubation Success Rate.	30; 30	—
SECONDARY Number of Esophageal Intubation.	4; 0	—
SECONDARY Number of Participants With Airway Trauma	3; 1	—

Summary

The Airtraq optical laryngoscope has recently been available in pediatric sizes. The investigators compared the efficacy of Airtraq with the Miller laryngoscope as intubation devices in paediatric patients. This prospective, randomized study was conducted in a tertiary care teaching hospital. Sixty American Society of Anesthesiologists (ASA) grade I-II paediatric patients of 2-10 years, posted for routine surgery requiring tracheal intubation were randomly allocated to undergo intubation using a Miller (n = 30) or Airtraq (n = 30) laryngoscope. The primary outcome measures were time of intubation, ease of intubation, number of attempts and POGO score. We also measured hemodynamic changes and airway trauma.

Eligibility Criteria

Inclusion Criteria

American Society of Anesthesiologists physical status I-II,
elective surgeries requiring tracheal intubation

Exclusion Criteria

patients with upper respiratory tract symptoms,
those at risk of gastroesophageal regurgitation and
those with airway-related conditions such a trismus, limited mouth opening, trauma or mass.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02423317). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.